Brian Goff

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, CT
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
James Basta, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Brian Goff

Form 4 holding Chief Executive Officer, Director

AGIOS PHARMACEUTICALS, INC.

Security class
Performance share units
Shares / value
40,500
Estimated value
$3,399,519
Report date
02 Apr 2026
Price
$44.39
Ownership
Direct
Underlying class
Common stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

AGIOS PHARMACEUTICALS, INC.

Security class
Restricted stock units
Shares / value
26,000
Estimated value
$1,279,440
Report date
02 Mar 2026
Price
$35.54
Ownership
Direct
Underlying class
Common stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

AGIOS PHARMACEUTICALS, INC.

Security class
Stock options (right to buy)
Shares / value
174,000
Estimated value
Report date
01 Mar 2026
Price
Ownership
Direct
Underlying class
Common stock
Underlying amount
Form 4 holding EVP & Chief Commercial Officer

ALEXION PHARMACEUTICALS, INC.

Security class
Common Stock, par value $.0001 per share
Shares / value
0
Estimated value
Report date
21 Jul 2021
Price
$177.00
Ownership
Direct
Form 4 holding EVP & Chief Commercial Officer

ALEXION PHARMACEUTICALS, INC.

Security class
Option to Purchase Common Stock
Shares / value
0
Estimated value
Report date
21 Jul 2021
Price
$155.01
Ownership
Direct
Underlying class
Common Stock, par value $.0001 per share
Underlying amount

Insider Reports Filed by Brian Goff

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .